Back to All Events

Insider Insights Tom Reeves, OBIO Director and President & Chief Executive Officer of Interface Biologics.

Q & A with Tom Reeves, President and CEO of Interface Biologics. Interface has successfully grown through the stages from Bench, to Start Up, to clinical Market Leader. Find out how they did it!

Previous
Previous
October 23

Great Governance for Growth

Next
Next
November 29

OBIO EXECUTIVE EXCHANGE SERIES: OPTIMIZING CLINICAL STATEGIES TO DRIVE REIMBURSEMENT